Anti-BCMA CAR-T Cells

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
BPS-78660-1	1 vial		-	-	3 - 15 business days*		2,234.00€
BPS-78660-2	5 vials		-	-	3 - 15 business days*		5,676.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary... more

Close menu

Product information "Anti-BCMA CAR-T Cells"

The anti-BCMA CAR-T cells are produced by high-titer lentiviral transduction of human primary CD4+CD8+ T cells using the anti-BCMA CAR Lentivirus (BPS-78655). These ready-to-use CAR-T cells express an anti-BCMA CAR consisting of the ScFv of BCMA (clone C11D5.3) linked to a 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge and transmembrane domains, and the 4-1BB and CD3zeta signaling domains. These CAR-T cells have been validated using flow cytometry (to determine the CAR expression) and co-culture cytotoxicity assays.

Keywords:	BCM, CD269, TNFRSF17, B-cell maturation protein, Tumor necrosis factor receptor superfamily member 17,
Supplier:	BPS Bioscience
Supplier-Nr:	78660

Properties

Application:	Positive control, inhibitor/activator screening, co-culture cytotoxicity assay design/optimization
Species reactivity:	human

Database Information

KEGG ID :	K05153 \| Matching products
UniProt ID :	Q02223 \| Matching products
Gene ID :	GeneID 608 \| Matching products

Handling & Safety

Storage:	Liquid nitrogen
Shipping:	-80°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Anti-BCMA CAR-T Cells"

Write a review